PATENT CLAIM ANALYSIS

Application Number: 15746964
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "168000"]

Abstract:
The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

Claim (Index 18):
A method for treating an inflammatory disorder or autoimmune disorder, comprising administrating an effective amount of the compound of  claim 1  to a cell or a subject.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 86.0
- Lexical Diversity: 1.36111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12555018', '12309459', '14790978', '13906626', '14592801']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7852912198766552
- 35 USC 102 Novelty (BERT): 0.5103426746712078
- Combined Prediction Score: 0.7577963653561105
- Mean Citation Score: 266.204172
- Max Citation Score: 272.8594
- Similarity Product: 181.8980589256525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test